Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide, is estimated to affect more than 16 million people in the US,1 and is the fourth leading cause of death in the US.2 COPD causes disabling physical and psychosocial symptoms for patients and adversely affects caregivers. Hospitalizations for COPD exacerbations are a key contributor to morbidity, mortality, and health care costs for individuals with COPD.3 Evidence-based interventions that reduce mortality are needed and would be welcomed by patients with COPD and clinicians alike.